A small-molecule MEK inhibitor reduced the effect of ICAM2 siRNA on cancer cell migration and invasion, suggesting that ICAM2 inhibits cancer cell migration and invasion at least in part through the suppression of the MEK-ERK signaling pathway. The gene discussed is ICAM2; the disease is cancer.